HUP0101712A3 - Heterocyclic derivatives which inhibit factor xa and pharmaceutical compositions containing them - Google Patents
Heterocyclic derivatives which inhibit factor xa and pharmaceutical compositions containing themInfo
- Publication number
- HUP0101712A3 HUP0101712A3 HU0101712A HUP0101712A HUP0101712A3 HU P0101712 A3 HUP0101712 A3 HU P0101712A3 HU 0101712 A HU0101712 A HU 0101712A HU P0101712 A HUP0101712 A HU P0101712A HU P0101712 A3 HUP0101712 A3 HU P0101712A3
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- heterocyclic derivatives
- inhibit factor
- inhibit
- Prior art date
Links
- 108010074860 Factor Xa Proteins 0.000 title 1
- 125000000623 heterocyclic group Chemical group 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9809351.1A GB9809351D0 (en) | 1998-05-02 | 1998-05-02 | Heterocyclic derivatives |
| GBGB9903337.5A GB9903337D0 (en) | 1999-02-16 | 1999-02-16 | Heterocyclic derivatives |
| PCT/GB1999/001308 WO1999057113A1 (en) | 1998-05-02 | 1999-04-27 | Heterocyclic derivatives which inhibit factor xa |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0101712A2 HUP0101712A2 (hu) | 2001-11-28 |
| HUP0101712A3 true HUP0101712A3 (en) | 2003-01-28 |
Family
ID=26313572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0101712A HUP0101712A3 (en) | 1998-05-02 | 1999-04-27 | Heterocyclic derivatives which inhibit factor xa and pharmaceutical compositions containing them |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US6753331B1 (hu) |
| EP (2) | EP1528061A1 (hu) |
| JP (1) | JP2002513790A (hu) |
| KR (1) | KR20010043246A (hu) |
| CN (1) | CN1133634C (hu) |
| AT (1) | ATE282610T1 (hu) |
| AU (1) | AU754453B2 (hu) |
| BR (1) | BR9910179A (hu) |
| CA (1) | CA2331042A1 (hu) |
| DE (1) | DE69921994T2 (hu) |
| EE (1) | EE200000527A (hu) |
| ES (1) | ES2232131T3 (hu) |
| HK (1) | HK1034711A1 (hu) |
| HU (1) | HUP0101712A3 (hu) |
| IL (1) | IL139406A (hu) |
| NO (1) | NO320893B1 (hu) |
| NZ (1) | NZ507835A (hu) |
| PL (1) | PL343706A1 (hu) |
| PT (1) | PT1082321E (hu) |
| SI (1) | SI1082321T1 (hu) |
| SK (1) | SK16512000A3 (hu) |
| TR (1) | TR200003200T2 (hu) |
| WO (1) | WO1999057113A1 (hu) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL115420A0 (en) | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
| GB9902989D0 (en) * | 1999-02-11 | 1999-03-31 | Zeneca Ltd | Heterocyclic derivatives |
| GB9914342D0 (en) * | 1999-06-19 | 1999-08-18 | Zeneca Ltd | Compound |
| GB9917344D0 (en) * | 1999-07-24 | 1999-09-22 | Zeneca Ltd | Novel salt |
| TWI288745B (en) | 2000-04-05 | 2007-10-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
| GB0012448D0 (en) | 2000-05-24 | 2000-07-12 | Astrazeneca Ab | New process |
| WO2002038184A1 (en) * | 2000-11-09 | 2002-05-16 | Astrazeneca Ab | Oral pharmaceutical composition containing a block copolymer |
| GB0104752D0 (en) * | 2001-02-27 | 2001-04-18 | Astrazeneca Ab | Pharmaceutical compositions |
| WO2003000657A1 (fr) | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Derives de diamine |
| US7479502B2 (en) | 2002-12-03 | 2009-01-20 | Pharmacyclics, Inc. | 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors |
| WO2004108671A1 (en) * | 2003-06-06 | 2004-12-16 | Suven Life Sciences Limited | Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them |
| EP1650206A4 (en) * | 2003-08-01 | 2006-12-20 | Nippon Soda Co | PHENYLAZOLE COMPOUNDS, PROCESS FOR THEIR PRODUCTION AND ANTIOXIDANTS |
| SE0400014D0 (sv) * | 2004-01-08 | 2004-01-08 | Astrazeneca Ab | Heterocyclic derivatives |
| CN101218227A (zh) * | 2005-07-08 | 2008-07-09 | 阿斯利康(瑞典)有限公司 | 作为因子Xa的抑制剂的杂环磺酰胺衍生物 |
| WO2007008144A1 (en) * | 2005-07-08 | 2007-01-18 | Astrazeneca Ab | Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| WO2007008145A1 (en) * | 2005-07-08 | 2007-01-18 | Astrazeneca Ab | Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| WO2007008143A1 (en) * | 2005-07-08 | 2007-01-18 | Astrazeneca Ab | Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| PL3762368T3 (pl) | 2018-03-08 | 2022-06-06 | Incyte Corporation | ZWIĄZKI AMINOPIRAZYNODIOLOWE JAKO INHIBITORY PI3K-γ |
| WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
| US20220380478A1 (en) | 2019-07-01 | 2022-12-01 | Tonix Pharma Holdings Limited | Anti-cd154 antibodies and uses thereof |
| EP4274587A1 (en) | 2021-01-06 | 2023-11-15 | Tonix Pharma Limited | Methods of inducing immune tolerance with modified anti-cd154 antibodies |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL115420A0 (en) * | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
| JP2001502655A (ja) * | 1995-12-21 | 2001-02-27 | デュポン ファーマシューティカルズ カンパニー | Ｘａ因子阻害薬であるイソオキサゾリン、イソチアゾリンおよびピラゾリン |
| GB9602166D0 (en) * | 1996-02-02 | 1996-04-03 | Zeneca Ltd | Aminoheterocyclic derivatives |
| GB9602294D0 (en) * | 1996-02-05 | 1996-04-03 | Zeneca Ltd | Heterocyclic compounds |
| UA56197C2 (uk) * | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Гетероциклічні похідні |
| EP0986551B1 (en) | 1997-05-30 | 2006-08-02 | Takeda Pharmaceutical Company Limited | Sulfonamide derivatives, their production and use |
| GB9715894D0 (en) * | 1997-07-29 | 1997-10-01 | Zeneca Ltd | Heterocyclic derivatives |
| DE19743435A1 (de) * | 1997-10-01 | 1999-04-08 | Merck Patent Gmbh | Benzamidinderivate |
-
1999
- 1999-04-27 JP JP2000547083A patent/JP2002513790A/ja active Pending
- 1999-04-27 EP EP04022155A patent/EP1528061A1/en not_active Withdrawn
- 1999-04-27 DE DE69921994T patent/DE69921994T2/de not_active Expired - Lifetime
- 1999-04-27 EP EP99918178A patent/EP1082321B1/en not_active Expired - Lifetime
- 1999-04-27 WO PCT/GB1999/001308 patent/WO1999057113A1/en not_active Application Discontinuation
- 1999-04-27 CN CNB99808218XA patent/CN1133634C/zh not_active Expired - Fee Related
- 1999-04-27 TR TR2000/03200T patent/TR200003200T2/xx unknown
- 1999-04-27 SK SK1651-2000A patent/SK16512000A3/sk unknown
- 1999-04-27 US US09/674,559 patent/US6753331B1/en not_active Expired - Fee Related
- 1999-04-27 PL PL99343706A patent/PL343706A1/xx not_active Application Discontinuation
- 1999-04-27 EE EEP200000527A patent/EE200000527A/xx unknown
- 1999-04-27 IL IL13940699A patent/IL139406A/en not_active IP Right Cessation
- 1999-04-27 BR BR9910179-3A patent/BR9910179A/pt not_active Application Discontinuation
- 1999-04-27 KR KR1020007012193A patent/KR20010043246A/ko not_active Application Discontinuation
- 1999-04-27 ES ES99918178T patent/ES2232131T3/es not_active Expired - Lifetime
- 1999-04-27 HU HU0101712A patent/HUP0101712A3/hu unknown
- 1999-04-27 NZ NZ507835A patent/NZ507835A/xx unknown
- 1999-04-27 SI SI9930725T patent/SI1082321T1/xx unknown
- 1999-04-27 AU AU36206/99A patent/AU754453B2/en not_active Ceased
- 1999-04-27 AT AT99918178T patent/ATE282610T1/de not_active IP Right Cessation
- 1999-04-27 PT PT99918178T patent/PT1082321E/pt unknown
- 1999-04-27 CA CA002331042A patent/CA2331042A1/en not_active Abandoned
-
2000
- 2000-11-01 NO NO20005497A patent/NO320893B1/no unknown
-
2001
- 2001-07-26 HK HK01105226A patent/HK1034711A1/xx not_active IP Right Cessation
-
2004
- 2004-04-06 US US10/817,960 patent/US20040266759A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HK1034711A1 (en) | 2001-11-02 |
| US6753331B1 (en) | 2004-06-22 |
| AU3620699A (en) | 1999-11-23 |
| EP1082321A1 (en) | 2001-03-14 |
| NZ507835A (en) | 2003-01-31 |
| IL139406A0 (en) | 2001-11-25 |
| NO20005497L (no) | 2000-12-21 |
| EP1082321B1 (en) | 2004-11-17 |
| IL139406A (en) | 2004-07-25 |
| ATE282610T1 (de) | 2004-12-15 |
| PT1082321E (pt) | 2005-03-31 |
| CN1133634C (zh) | 2004-01-07 |
| HUP0101712A2 (hu) | 2001-11-28 |
| ES2232131T3 (es) | 2005-05-16 |
| EE200000527A (et) | 2002-02-15 |
| SK16512000A3 (sk) | 2001-05-10 |
| BR9910179A (pt) | 2001-01-09 |
| KR20010043246A (ko) | 2001-05-25 |
| CN1308631A (zh) | 2001-08-15 |
| AU754453B2 (en) | 2002-11-14 |
| PL343706A1 (en) | 2001-08-27 |
| DE69921994T2 (de) | 2005-12-01 |
| CA2331042A1 (en) | 1999-11-11 |
| NO20005497D0 (no) | 2000-11-01 |
| TR200003200T2 (tr) | 2001-02-21 |
| JP2002513790A (ja) | 2002-05-14 |
| SI1082321T1 (en) | 2005-06-30 |
| US20040266759A1 (en) | 2004-12-30 |
| DE69921994D1 (de) | 2004-12-23 |
| WO1999057113A1 (en) | 1999-11-11 |
| NO320893B1 (no) | 2006-02-06 |
| EP1528061A1 (en) | 2005-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0101810A3 (en) | Substituted oxoazaheterocyclyl factor xa inhibitors and pharmaceutical compositions containing them | |
| IL139479A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL148517A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL150077A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL149473A0 (en) | Heterocyclic dihydropyrimidine derivatives and pharmaceutical compositions containing the same | |
| IL145428A0 (en) | Alkanoyl-substituted heterocyclic derivatives and pharmaceutical compositions containing the same | |
| HUP0101712A3 (en) | Heterocyclic derivatives which inhibit factor xa and pharmaceutical compositions containing them | |
| HUP0103256A3 (en) | Thiobenzimidazole derivatives and pharmaceutical compositions containing the compounds | |
| IL144592A0 (en) | Heterocyclic aromatic compounds and pharmaceutical compositions containing the same | |
| IL138899A0 (en) | Amidene derivatives and pharmaceutical compositions containing the same | |
| IL142665A0 (en) | Acyl dipeptidyl derivatives and pharmaceutical compositions containing the same | |
| HUP0203378A3 (en) | Pharmaceutical compounds and pharmaceutical compositions containing them | |
| HUP0103406A3 (en) | 1h-imidazopyridine derivatives and pharmaceutical compositions thereof | |
| IL138573A0 (en) | Amide derivatives and pharmaceutical compositions containing the same | |
| HUP0102990A3 (en) | Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof | |
| IL143920A0 (en) | 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same | |
| HUP0003362A3 (en) | Piperidine derivatives and pharmaceutical compositions containing them | |
| HUP0101381A3 (en) | Benzofurylpyrone derivatives and pharmaceutical compositions containing them | |
| IL149883A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL157740A0 (en) | Heterocyclic derivatives and pharmaceutical compositions containing the same | |
| HUP0201714A2 (en) | Substituted heterocyclic compounds and pharmaceutical compositions containing them | |
| IL143802A0 (en) | Imidazole derivatives and pharmaceutical compositions containing the same | |
| IL147214A0 (en) | 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same | |
| HUP0103896A3 (en) | Oxygenic heterocyclic compounds pharmaceutical compositions containing them and their use | |
| HUP0103203A3 (en) | Azaadamantane derivatives and pharmaceutical compositions thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |